These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35465367)

  • 1. Effects of exercise on serum ischemia-modified albumin, brain natriuretic peptide and copeptin levels in boxers and kick boxers.
    Memmedov H; Bakan E; Ozturk N; Baygutalp NK; Kaynar O; Gul MA; Kaya A; Kıyıcı F; Yazıcı AG
    Pan Afr Med J; 2022; 41():98. PubMed ID: 35465367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Assessment of Copeptin and Brain Natriuretic Peptide Levels as Biomarkers in Hypertensive Disorders of Pregnancy.
    Okwor CJ; Adedapo KS; Bello OO; Adedapo AD; Okwor VC
    West Afr J Med; 2020; 37(3):231-236. PubMed ID: 32476116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps.
    Sari K; Gencer ZK; Ede H; Gocmen AY; Kantekin Y
    Auris Nasus Larynx; 2016 Oct; 43(5):529-36. PubMed ID: 26795264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor.
    Kurz K; Voelker R; Zdunek D; Wergeland R; Hess G; Ivandic B; Katus H; Giannitsis E
    Clin Res Cardiol; 2007 Mar; 96(3):152-9. PubMed ID: 17180576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide.
    Zurek M; Maeder MT; Brutsche MH; Lüthi A; Twerenbold R; Freese M; Rickli H; Mueller C
    Eur J Appl Physiol; 2014 Apr; 114(4):815-24. PubMed ID: 24390725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Copeptin and ischemia modified albumin in early diagnosis and prognosis of myocardial damage in acute organic phosphorus pesticide poisoning].
    Li J; Zhang J; Li N; Li J; Liu J; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):459-62. PubMed ID: 25818801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
    Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
    Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning.
    Li J; Wang JS; Xie ZX; Wang WZ; Wang L; Ma GY; Li YQ; Wang P
    Genet Mol Res; 2015 Sep; 14(3):10384-9. PubMed ID: 26345979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of plasma brain natriuretic peptide concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy.
    Baumwart RD; Meurs KM
    Am J Vet Res; 2005 Dec; 66(12):2086-9. PubMed ID: 16379651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia.
    Falkensammer J; Stojakovic T; Huber K; Hammerer-Lercher A; Gruber I; Scharnagl H; Fraedrich G; Santner W; Schocke M; Greiner A
    Clin Chem Lab Med; 2007; 45(4):535-40. PubMed ID: 17439334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum copeptin level can be a helpful biomarker in evaluation of myocardial perfusion scintigraphy results.
    Ede H; Karaçavuş S; Göçmen AY; Yaylak B; Akkaya S; Açıkgöz B; Çilek N; Kılıç M; Erbay AR
    Cardiol J; 2016; 23(1):71-7. PubMed ID: 26100831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease.
    Li X; Yang XC; Sun QM; Chen XD; Li YC
    Chin Med J (Engl); 2013 Mar; 126(5):823-7. PubMed ID: 23489784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia-modified Albumin as a Biomarker for Prediction of Poor Outcome in Patients With Traumatic Brain Injury: An Observational Cohort Study.
    Radwan TAM; Fahmy RS; El Emady MFM; Khedr ASEDM; Osman SH; ElSonbaty MI; El-Kholy BMB; Thabit MA; Elkatatny AM
    J Neurosurg Anesthesiol; 2021 Jul; 33(3):254-257. PubMed ID: 31584483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
    Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
    J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with spect perfusion imaging.
    Zaid G; Tanchilevitch A; Rivlin E; Gropper R; Rosenschein U; Lanir A; Goldhammer E
    Int J Cardiol; 2007 Apr; 117(2):157-64. PubMed ID: 16997398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of novel biomarkers to BNP infusion in patients with decompensated heart failure: a multimarker paradigm.
    Miller WL; Hartman KA; Hodge DO; Hartman S; Struck J; Morgenthaler NG; Bergmann A; Jaffe AS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):526-35. PubMed ID: 20560012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.